Cut-off 0–27 vs. 28+ | Cut-off 0–21 vs. 22+ | AUC | (95% CI) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Sens. | Spec. | PPV | NPV | Sens. | Spec. | PPV | NPV | |||
CBCL | ||||||||||
Totalb | 33.3% | 98.4% | 66.7% | 93.8% | 71.7% | 93.0% | 50.0% | 97.1% | 0.94 | (0.92–0.96) |
Internalisingc | 24.4% | 98.3% | 66.7% | 90.4% | 53.7% | 92.9% | 51.2% | 93.5% | 0.89 | (0.86–0.92) |
Externalisingd | 30.8% | 97.7% | 53.3% | 94.4% | 57.7% | 91.0% | 34.9% | 96.3% | 0.90 | (0.87–0.93) |
Currently under treatment | 18.9% | 96.8% | 33.3% | 93.3% | 47.2% | 90.2% | 29.1% | 95.2% | 0.80 | (0.74–0.86) |